Evolution of the Average Target: Santhera Pharmaceuticals Holding AG

Evolution of the Target Price: Santhera Pharmaceuticals Holding AG

Changes in Analyst Recommendations: Santhera Pharmaceuticals Holding AG

e1b4bfe25f4f723f7c.kbeN9klUPnyTvUCqU4KYMydo_V4QZk8XwjkBkQHHgqM.9ebgz30ACy7bixrDI8D3aXErpzB6DylCqnRs9mOR05LJjuigKi5YBvHWdA~b3726611fd8b73ff5d895e0a896617f7

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+3.28%
+14.23%
-12.59%
+0.65%
+72.82%
+53.77%
- - -16.75%
+44.75%
Average +20.02%
Weighted average by Cap. +5.54%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.22CHF
Average target price
27.50CHF
Spread / Average Target
+80.68%
High Price Target
30.00CHF
Spread / Highest target
+97.11%
Low Price Target
25.00CHF
Spread / Lowest Target
+64.26%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. SANN Stock
  4. SPHDF Stock
  5. Consensus Santhera Pharmaceuticals Holding AG